Enzo Biochem (NYSE:ENZ) Coverage Initiated by Analysts at StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of Enzo Biochem (NYSE:ENZ) in a research note issued to investors on Wednesday. The brokerage set a “hold” rating on the medical research company’s stock.

Enzo Biochem Stock Performance

Shares of ENZ stock opened at $0.50 on Wednesday. Enzo Biochem has a 12 month low of $0.41 and a 12 month high of $1.40. The company’s fifty day moving average price is $0.68 and its 200-day moving average price is $0.96.

Enzo Biochem (NYSE:ENZ) last announced its earnings results on Monday, December 16th. The medical research company reported ($0.05) EPS for the quarter. Enzo Biochem had a negative net margin of 75.34% and a negative return on equity of 7.96%.

Institutional Trading of Enzo Biochem

Hedge funds have recently modified their holdings of the business. Virtu Financial LLC bought a new stake in shares of Enzo Biochem during the 4th quarter valued at $35,000. BBR Partners LLC purchased a new position in shares of Enzo Biochem in the 3rd quarter worth about $112,000. Lepercq De Neuflize Asset Management LLC purchased a new position in shares of Enzo Biochem in the 4th quarter worth about $88,000. Wittenberg Investment Management Inc. raised its position in shares of Enzo Biochem by 60.1% in the 4th quarter. Wittenberg Investment Management Inc. now owns 187,537 shares of the medical research company’s stock worth $134,000 after purchasing an additional 70,400 shares during the last quarter. Finally, Geode Capital Management LLC raised its position in shares of Enzo Biochem by 3.3% in the 3rd quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock worth $413,000 after purchasing an additional 11,742 shares during the last quarter. Institutional investors own 36.90% of the company’s stock.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.